Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0JF3M
|
|||
| Former ID |
DIB015768
|
|||
| Drug Name |
P-144
|
|||
| Indication | Ulcer [ICD-11: CA02-CB40; ICD-10: K25-K27; ICD-9: 531-534] | Phase 2 | [1] | |
| Age-related macular degeneration [ICD-11: 9B75.0; ICD-9: 362.5] | Investigative | [2] | ||
| Company |
Digna Biotech SL
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00781053) Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study. U.S. National Institutes of Health. | |||
| REF 2 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.